MEMORANDUM OPINION AND ORDER
I.
Maxon Corporation (“Maxon”) designs and manufactures a range of products for use in combustion and gas regulation systems. These include burner assemblies (“burners”), a wide variety of valves 1 (safety shut off. micro-ratio and control), and pipe or gas trains (sequences of pipe, valves, regulators, meters and other equipment through which natural gas is supplied — from a gas line to a burner, burner assembly or other industrial apphcation). Their products are offered to various customers, including firms in the automotive industry.
*880 Industrial Burner Systems (“IBS”) supplies, designs and services parts and equipment for use in combustion and gas regulation systems. At least one company, Eclipse Products (“Esclipse”), which IBS serves as a manufacturer’s representative for, designs and manufactures industrial burners. 2 Approximately 70% of IBS’ business is derived from the sale of gas trains, with the residual coming from the sale of parts for gas trains. 85% of its gas trains are sold for use in automotive industry applications. 3 IBS purchases Maxon parts to be used as components in its gas trains.
Since 1974, Maxon has had a policy of offering various prices to customers “based on the nature of their operations.” See Maxon’s Motion for Summary Judgment, at 2. There is one price for burners and another for valves and gas trains (these prices are usually expressed by a pair of numbers' — the first for burners, the second for valves). The price at which each product is offered is based upon a classification assigned by Maxon to the purchaser. The immediately relevant classifications for burners are: List, Resaler and Original Equipment Manufacturer (“OEM”). There are two relevant classifications for valves: Wholesaler and OEM. Any purchaser of valves or burners qualifying for OEM status, “based on the nature of their business,” 4 is given the benefit of a substantial price reduction. IBS alleges that all of its competitors in the automotive industry gas train market have been given OEM status, while it has been specifically denied the OEM classification. 5 The record indicates that IBS was classified as a Resaler (for burners) and a Wholesaler (for valves). Therefore, whenever IBS purchased burners or valves from Maxon it paid more than it would have had it been listed as an OEM. Maxon also provides discounts for parties who agree to blanket purchase orders at set volumes at the start of a year (“BOD”). 6 *881 Additionally, individual orders of sufficient size are eligible for volume discounts.
The specific market structure at issue has three relevant levels. First, the component parts manufacturing level (primary-line), where Maxon and Eclipse design and manufacture, and Maxon sells, burners and valves. 7 Second, the gas train manufacturing level (secondary-line), where IBS, Maxon and the other gas train manufacturers (“Competitors”) assemble parts from the primary-line into gas trains that are then offered to customers. 8 Finally, the customer level (tertiary-line), where companies, such as tier-1 auto suppliers, purchase the finished gas trains.
Transactions reaching the tertiary-line follow a specific process. First, the tertiary-line customer solicits bids for gas trains from the secondary-line companies. Second, secondary-line companies get quotes on valves and burners from the primary-line before calculating their bids. Third, with primary-line quotes in hand, the secondary-line companies then submit their competitive bids to the tertiary-line. Thus, even though a purchase may appear prospective in nature, it is for the purpose of the market for the bid, actual in fact. 9 Fourth, the tertiary-line customer then chooses the lowest bid (the amount of which is inclusive of the already-determined price for the primary-line parts). 10 Finally, once the bid is secured, the secondary-line company retrieves the parts from the primary-line at the pre-estab-lished price.
In July 2002, IBS brought the present suit. The claim is an allegation of price discrimination under the Robinson-Pat-man Act, 15 U.S.C. § 13(a), seeking treble damages. Subsequent to the filing of this suit, Maxon completely terminated its relationship with IBS. IBS sought a preliminary injunction to compel Maxon to continue honoring purchase orders submitted to Maxon, but was denied. Ross Flora, the President of IBS, indicated that IBS had been able to obtain an alternative source for Maxon products, but at a higher price than those previously paid by IBS to Max-on. 11 IBS is pursuing a claim for “lost profits,” based on the theory that IBS had lost various jobs for gas trains over the years because of bid prices.
Maxon has now moved for summary judgment under Fed.R.Civ.P. 56(c).
II.
Although both the Supreme Court and this circuit have emphasized that Rule 56 makes absolutely no distinction between
*882
antitrust and other cases,
see First National Bank of Arizona v. Cities Service Co.,
III.
Section 2(a) of the Robinson-Patman Act provides, in pertinent part, as follows:
It shall be unlawful for any person engaged in commerce, in the course of such commerce, either directly or indirectly, to discriminate in price between different purchasers of commodities of like grade and quality.. .where the effect of such discrimination may be substantially to lessen competition or tend to create a monopoly in any line of commerce, or to injure, destroy, or prevent competition with any person who either grants or knowingly receives the benefit of such discrimination, or with customers of either of them.
15 U.S.C. § 13(a).
Price discrimination claims generally fall into three categories.
See George Haug Co. v. Rolls Royce Motor Cars, Inc.,
To establish secondary-line price discrimination under section 2(a), a plaintiff has the burden of establishing four things: (1) that seller’s sales were made in interstate commerce; (2) that the seller discriminated in price as between the two purchasers; (3) that the product or commodity sold to the competing purchasers was of the same grade and quality; and (4) that the price discrimination had a prohibited effect on competition.
See Haug,
Maxon has not argued that the sales in question were not made in interstate commerce, that the products sold to IBS and its competitors were not of “like grade and quality” or whether there was, in fact, a “price discrimination.” 14 Instead, Maxon asserts that: (1) because there were never two “contemporaneous” purchases, there could never be discrimination within the meaning of the Robinson-Patman Act; and, (2) because of the market structure inherent in competitive bidding, there could, as a matter of law, be no “competitive injury.” Next, Maxon avers that IBS is unable to prove antitrust injury, i.e., a present injury that is actually traceable to the benefits conferred upon the favored competitor. Finally, a statute of limitations defense is made.
Comemporaneous
Section 2(a) of the Robinson-Pat-man Act “requires that each purchaser be given an ‘equal opportunity’ by the seller to receive the benefit of higher or lower prices.”
Haug,
In
Innomed Labs, LLC v. Alza Corp.,
the defendant similarly argued that, because the distribution agreements for the competitor and the plaintiff were executed at different times, i.e., one in August 1997, and the other in December 1997, the plaintiff could not show that the price discrimination was “contemporaneous.” as required under the Robinson-Patman Act.
*884
In the course of the same litigation, but upon a different motion, the court again clarified that Robinson-Patman merely “requires that the sales, which form the basis of the discrimination, must be reasonably proximate in time.”
Innomed Labs, LLC v. Alza Corp.,
Maxon cites
Shavrnoch v. Clark Oil and Refining Corp.,
Competitive Injury
Maxon’s second argument is aimed at the requirement that the price discrimination had a prohibited effect on competition. To resolve this issue, it must first be determined what degree and type of market consequences will constitute the proscribed statutory effect upon competition within a case of secondary-line price discrimination?
The proper secondary-line competitive injury analysis is set forth in Haug, 148 *885 F.3d at 140. From the beginning, the court notes that “it is hornbook law ... that anti-competitive injury need not be alleged to sustain a claim for violation of the Robinson-Patman Act; a price differential, direct or indirect, between secondary-line competitors is enough. The Act requires that each purchaser be given an ‘equal opportunity by the seller to receive the benefit of higher or lower prices.” Id.
However, “[as] a prerequisite to establishing competitive injury in a secondary line price discrimination case, a plaintiff must prove that ‘it was engaged in actual competition with the favored purchaser(s) as of the time of the price differential.’ ”
Id.
at 141 (citing
Best Brands,
Actual Competition
“Determining the presence or absence of functional competition between purchasers of a commodity is simply a factual process which focuses on whether these purchasers were directly competing for resales among the same group of customers.”
Haug,
To satisfy the ‘competitive nexus’ requirement, “ ‘it must ... be shown that, as of the time the price differential was imposed, the favored and disfavored purchasers competed at the same functional level, i.e., all wholesalers or all retailers, and within the same geographic market.’ ”
Id.
at 141-42 (quoting
Best Brands Beverage, Inc.,
In an attempt to argue that there was no actual competition, Maxon asserts that:
“If IBS buys a Maxon product, it is the only relevant sale Maxon makes — IBS has eliminated all competition, regardless of what Maxon quoted to any potential competitor, before IBS ever buys. Therefore, by the time IBS buys anything, no potential or actual harm to competition or IBS’ ability to compete could be caused by the purchase itself.” See Maxon’s Motion for Summary Judgment, at 11.
Closely tracking the reasoning of its “contemporaneous” sales argument, Max-on avers that there cannot be a prohibited impact on competition from the sale to IBS because there are not two sales and effectively no competition. Maxon bases its approach to Robinson-Patman on language in
M.C. Manufacturing Co., Inc. v. Texas Foundries, Inc.,
As an initial matter, this approach unnecessarily blends the “separate purchaser” requirement found in the second price discrimination factor, with the competitive injury requirement found in the fourth factor. More importantly, this interpretation overlooks the practical impact of the competition in the bidding process — the relevant competitive market — by focusing on the after-the-matter “purchase.” In a bid-contract structure, this purchase is, for purposes of the competition for the bid, a second symbolic purchase.
Moreover, the fact-specific holding of
M.C. Manufacturing
is readily distinguishable from the present circumstances. First, the plaintiffs claim in that case was “analogous to the situation where ... [the] buyers are not in competition for the same ultimate users.”
Second, the court in
M.C. Manufacturing
took note
of
a special exception “to the two-purchaser requirement where competitors in the same market are engaged in competitive purchasing and selling at the time of the price discrimination and where the failure of the plaintiff to consummate a second purchase of the item discriminatorily priced is directly attributable to defendant’s own discriminatory practice.”
Maxon rightly notes that the Sixth Circuit has not specifically addressed the fact pattern in
M.C. Manufacturing.
Additionally, Maxon asserts that the Sixth Circuit has stated that the relevant inquiry under Robinson-Patman is whether individual transactions, not an overall course of dealing, violate the statute.
See Cellar Door Productions, Inc. v. Kay,
Reasonable Probability That Competition Has Been Harmed
Once the existence of a competitive relationship has been established, the plaintiff must demonstrate a reasonable possibility that competition has been harmed as a result of the price differential.
See Haug,
In
FTC v. Morton Salt Co.,
In the present case, the price at which each product is offered is based upon a classification assigned by Maxon to the purchaser. As stated above, any purchaser of valves or burners qualifying for OEM status, “based on the nature of their business,” is given the benefit of a substantial price reduction. One way to demonstrate that a price discrimination is “substantial” is to demonstrate that it affects the resale price of the commodity.
See Morton Salt,
The Maxon Corporation Price And Commission Table (“Table”) demonstrates that a company listed as an OEM is offered the same item at a substantial discount from the prices offered to a Resaler, or Wholesaler, which are the classifications assigned to IBS. The discounts on valves and burners offered to the OEM classification range from 5.5 to 14%.
22
Other courts viewing discounts below even the lowest discounts present in the Table have found such amounts to be “substantial.”
See, e.g., Foremost Dairies, Inc. v. FTC,
The second step in determining if there is a “reasonable probability that competition has been harmed” requires the court to ask whether the price discrimination has lasted “over time.” In the present case, Mr. Flora alleges in his deposition that the OEM/non-OEM price classification was in place for a period of several years — possibly more than ten years.
23
A
*889
ten year period of price discrimination satisfies the duration deemed sufficient by other courts examining the issue.
See, e.g., Foremost Dairies v. FTC,
IV.
Antitrust Injury
Even if IBS is able to escape summary judgment on the first four factors discussed above, it must, if it is going to have standing to recover damages as a private plaintiff, demonstrate that it suffered actual injury to its business as a result of the price discrimination' — the antitrust injury requirement.
See Schwartz v. Sun Co.,
To establish antitrust injury, IBS has the burden of: (1) proving cognizable antitrust injury; and (2) providing at least a non-speculative approximation of its damages. See J. Truett Payne Co., supra.
Proving Cognizable Antitrust Injury
To establish cognizable antitrust injury, IBS must both demonstrate the existence of an injury and “that the challenged price discrimination is a
material
cause of that injury.”
Allied Accessories and Auto Parts Co., Inc. v. General Motors Corp.,
Because damage issues in these cases are rarely susceptible to the kind of concrete, detailed proof of injury which is available in other contexts, the Supreme Court has repeatedly held that in the absence of more precise proof, the factfinder may “conclude as a matter of just and reasonable inference from the proof of defendants’ wrongful acts and their tendency to injure plaintiffs’ business, and from the evidence of the decline in prices, profits and values, not shown to be attributable to other causes, that defendants’ wrongful acts had caused damage to the plaintiffs.” Bigelow v. RKO Pictures, Inc.,327 U.S. 251 , 264,66 S.Ct. 574 ,90 L.Ed. 652 (1946) (citations omitted).
Maxon argues that, even if IBS’ purchases could serve as the basis for a Robinson-Patman claim, the only evidence of antitrust injury that IBS has presented is the gross quantities of goods it has purchased from Maxon. Maxon further argues that IBS has not shown it ever lost a sale, profits or its value, based on the difference between what it and another customer paid Maxon — the injuries, according to it, that Robinson-Patman is designed to remedy.
Two situations are at issue in the present case: the first, is that which arises only on the occasion where there is an after-the-matter “purchase”; the second, is *890 the always-present competition to secure the bid.
In the situations where IBS has alleged that it suffers price discrimination in the after-the-matter “purchase,” it is inappropriate to grant summary judgment in Max-on’s favor. The Sixth Circuit has previously acknowledged that “whenever there is price discrimination ... the overall financial health of the disfavored purchaser will usually be affected for the worse.”
Schwartz v. Sun Co.,
In the instant case, however, the loss is not limited to the situation where IBS has made an after-the-matter “purchase” of the components. As described above, the relevant competition is for the bid. Moreover, losing out on a bid that is “always profitable,” a fact that Maxon has asserted in an attempt to undermine IBS’ attempt to establish cognizable antitrust injury, appears to cut the other way; loss of an “always profitable” bid is by definition a “lost profit.”
After bids are solicited by the tertiary-line customer, IBS and its Competitors get quotes on valves and burners from the primary-line
before
calculating their bids. Next, with primary-line quotes in hand, the secondary-line companies then submit their competitive bids to the tertiary-line. This moment is the relevant point of competition, and it is at this time that the discriminatory price will have
an
adverse impact on IBS’ ability to compete (potentially resulting in the loss of the contract for the gas trains because of a higher bid reasonably attributable to the higher costs for valves and/or burners that form a necessary component of the bid amount).
24
Thus, even though a purchase may appear prospective in nature, it is for the purpose of the market for the bid, actual in fact.
See Allied II,
When the tertiary-line customer then chooses the lowest bid (the amount of which is inclusive of the already-determined price for the primary-line parts), and the secondary-line company then re
*891
trieves the parts from the primary-line at the pre-established price, it is reasonable to conclude that the damage is already done. “Where there is evidence ... which tends to show that [the plaintiffs] losses were a result of defendant’s conduct, as well as evidence which tends to show that his losses were attributable to other factors, it is normally up to the trier of fact to decide which is the case.”
See Costner v. Blount Nat’l Bank Maryville, Tenn.,
Ncm-Speculative Approximation of Damages
In
Allied Accessories and Auto Parts Co., Inc. v. General Motors Corp., ("Allied I”),
the Sixth Circuit quoted
World of Sleep, Inc. v. Lar-Z-Boy Chair Co.,
If the plaintiff has demonstrated some damage, the actual amount need not be proven to the same degree of certainty. King & King [Enterprises v. Champlin Petroleum Co.,657 F.2d 1147 , 1158 (10th Cir.1981), cert. denied,454 U.S. 1164 ,102 S.Ct. 1038 ,71 L.Ed.2d 320 (1982) ]. “[A] plaintiff is not to be held to a rigid standard of proof regarding the amount of damages, since in such cases economic harm is frequently intangible and difficult to quantify.” Id. at 1157. “While the damages may not be determined by mere speculation or guess, it will be enough if the evidence show [sic] the extent of the damages as a matter of just and reasonable inference, although the result be only approximate. The wrongdoer is not entitled to complain that they cannot be measured with the exactness and precision that would be possible if the case, which he alone is responsible for making, were otherwise.” Story Parchment Co. v. Paterson Parchment Paper Co.,282 U.S. 555 , 563,51 S.Ct. 248 , 250,75 L.Ed. 544 (1931); see also Los Angeles Memorial Coliseum Comm’n v. NFL,791 F.2d 1356 (9th Cir.1986) (plaintiff need only provide sufficient evidence to submit a just and reasonable estimate of damages).
Maxon asserts that the evidence provided by IBS is speculative as a matter of law. Because, “[an approximation of ]damages is only speculative when the evidence is inadequate to supply the basis for [factual] determination,” see Id. at 975, this court disagrees.
As to the amount of damages flowing from the impact of the price discrimination on the competition for the bid, Flora, in his deposition, sets forth the basis for his calculations.
See
Flora Deposition, at 190-91, 202 (“I know the jobs I’ve lost on price. Valves are 50 percent of the price of a gas train ... I can identify jobs that I lost where I knew valves were a factor.”).
25
The Sixth Circuit has found previously that similar projections based on a plaintiffs experience can provide sufficient grounds for calculating damages.
Grand Rapids Plastics, Inc. v. Lakian,
As to the amount of damages flowing from the impact of the price discrimination on the after-the-matter “purchase,” IBS provides specific estimates for each of the past 10 years. See IBS’ Second Supplement to its Rule 26 Disclosures (Difference between the price charged to Plaintiff and prices for comparable parts charged to similarly situated customers for the years 1993-2002; 1993 — $9,006.29; 1994— $35,416.07; 1995 — $21,545.13; 1996— $36,062.31; 1997 — $12,246.41; 1998— $14,466.76; 1999 — $10,905.05; 2000— $34,247.45; 2001 — $8,455.91; 2002— $7,201.54). Again, Maxon has failed to provide adequate support for the proposition that such evidence is, as a matter of law, insufficient to show “the extent of the damages as a matter of just and reasonable inference, although the result be only approximate.” Allied I, at 973. 26 Accordingly, to the extent that Maxon’s motion for summary judgment is based on IBS’ “speculative approximation of damages,” it is denied. 27
y.
Primary-line
As set forth above, IBS states that it is a “manufacturer’s representative”] (i.e., sells burners) for Eclipse Products, whose manufacture (and therefore IBS’ sale) of burners is in “direct competition” with Maxon. Beyond that statement, however, IBS is completely silent on a potential primary-line price discrimination claim. 28 At the same time, in its Brief in Opposition to Defendant’s Motion for Summary Judgment, IBS claims that this is only a secondary-line case. Therefore, because the *893 claim has been disavowed, the court is not ruling on this issue of primary-line price discrimination in violation of Robinson-Patman.
VI.
Maxon’s Unilateral Refusal to Deal
IBS claims that when Maxon terminated its relationship with IBS, it violated Robinson-Patman. However, “[n]othing in the Robinson-Patman Act imposes upon a supplier an affirmative duty to sell to all potential customers ... [and] absent monopolistic power, a seller may refuse to deal with anyone.”
Ben B. Schwartz & Sons, Inc.,
In the instant case, IBS has failed to come forward with any evidence, or even allege, that the Maxon has “monopolistic power” within the relevant market. 29 The only statement concerning market presence — and, significantly, not market share — is that “Maxon is a $60,000,000 company with customers worldwide.” This information tells us nothing about Maxon’s monopolistic power within the relevant market. Accordingly, because IBS has failed to present any evidence creating a genuine issue of material fact as to Max-on’s monopolistic power, Maxon is entitled to summary judgment on IBS’ allegation that Maxon’s unilateral refusal to deal is a violation of Robinson-Patman.
VII.
Statute of Limitations
Finally, Maxon correctly points out that IBS has not attempted to defend its request for damages beyond the four year statute of limitations.
Grand Rapids Plastics,
There are, however, two exceptions to the general four-year statute of limitations that must be examined.
Kaiser Aluminum & Chemical Sales, Inc. v. Avondale Shipyards, Inc.,
The first of these is the “continuing violation” exception. The court in Grand Rapids Plastics, described the “continuing violation” exception as follows:
A continuing antitrust violation is one in which the plaintiffs interests are repeatedly invaded. When a continuing antitrust violation is alleged, a cause of action accrues each time the plaintiff is injured by an act of the defendants. Even when a plaintiff alleges a continuing violation, an overt act by the defendant is required to restart the statute of limitations and the statute runs from the last overt act .... An overt act that restarts the statute of limitations is characterized by two elements: (1) it must be a new and independent act that *894 is not merely a reaffirmation of a previous act; and (2) it must inflict new and accumulating injury on the plaintiff (citing DXS, Inc. v. Siemens Med. Sys., Inc.,100 F.3d 462 , 467-68 (6th Cir.1996) (internal quotations omitted)).188 F.3d 401 , 405-7 (6th Cir.1999). 30
The second, the “speculative damages” exception, stays the limitations period so that it does not begin to run until the damages are ascertainable.
Kaiser Aluminum & Chemical Sales,
Because IBS has been silent on the applicability of both exceptions to the statute of limitations, it cannot be said that it can meet its burden of proof. Accordingly, Maxon’s motion for summary judgment on the issue of the four year statute of limitations is granted.
yiii.
For the foregoing reasons,
IT IS ORDERED that Maxon’s summary judgment motion is hereby DENIED as to the secondary-line price discrimination claim, and GRANTED as to IBS’ claim that Maxon’s unilateral refusal to deal constituted a violation of Robinson-Patman, and GRANTED as to Maxon’s statute of limitations defense.
IT IS SO ORDERED.
Notes
. These valves can be configured in a number of ways, including the use of different kinds of switches, finishes or other options.
. IBS is a "manufacturer’s representative] (i.e., sells burners) for Eclipse Products (which manufactures burners among other products).” According to Richard Clasby, Maxon Vice-President for Sales, Eclipse’s manufacture (and therefore IBS’ sale) of burners is in "direct competition” with Max-on. Moreover, in answer to the question "(is there anybody else) you recognize as direct competitors (in the Detroit burner market),” Clasby replied "[n]ot really ... (and if there is) we don’t face them head to head in competition like we face IBS head to head, day in and day out.” See IBS’ Brief in Opposition to Defendant’s Motion for Summary Judgment.
. From 1992 until 2002, IBS’ total sales have remained between $4 and $5 million. During this same time, various companies have both started and stopped making gas trains (for example, DLB, which has given up production in favor of purchasing gas trains from IBS).
. What "based on the nature of their business” means is unclear. However, IBS alleges that, in his Deposition, Clasby "admitted that, when deciding which classification to assign to a customer, it considers whether that customer is a competitor of Maxon and that competitors are assigned higher prices. This is true even when the company is similarly situated and buying commodities of like grade and quality."See IBS’ Brief in Opposition to Defendant’s Motion for Summary Judgment, at 3. IBS further alleges that, through Clasby, Maxon has "admitted that it is trying to increase its market share — i.e., to reduce competition.” See Id. at 3-4. Finally, IBS alleges, that Maxon, again through Clasby, has "admitted that one of the reasons it has refused to classify IBS as an OEM was because IBS was a competitor of Maxon.” See Id.
. Thus, even though these companies may not differ from IBS in "the nature of their business,” they receive better prices from Maxon. IBS alleges that as a result the Competitors have a competitive advantage.
. A firm is eligible for a BOD if the given purchase exceeds $100,000 and/or the firm agrees to buy "x” ahead of time. IBS alleges that, even when it has met the BOD threshold, Maxon has never offered it a BOD.
. The primary-line may arguably include IBS in its capacity as a manufacturer's representative. However, in its response to Maxon’s motion for summary judgment. IBS argues that this lawsuit is only presenting a "secondary-line” Robinson-Patman claim.
. It is also possible that Maxon, as a primary-line manufacturer of valves, burners and other relevant parts, deals directly with tertiary-level customers (for the purpose of the gas train market) as secondary-line competitors (for their respective industrial applications). However, for the purposes of this instant motion Maxon’s relationship to those parties is described as falling within the tertiary-line.
. The relevant competition in this market is for the bid; and, at this point, the bids are reflective of purchase prices. Moreover, it is undisputed that the amount of the quotes given by Maxon to the secondary-line competitors are not dependent on securing the contract from the tertiary-line customer.
. All other things being equal, it is at least reasonable to determine that higher prices for given parts result in higher bid amounts and a lower likelihood of successfully producing a winning bid.
. As part of the discovery process, IBS produced bids or quotes from IBS that were pending or submitted after Maxon terminated its relationship with IBS. In making these disclosures, IBS also identified the categories and amount of its alleged damages.
. In their Response to Maxon's Motion for Summary Judgment, IBS asserts that this is "a secondary-line” Robinson-Patman case. See Plaintiff's Brief in Opposition, at 6. Whether this is an exclusive description of the case at hand will be more fully explored below.
. While section 2(a) affords defendants two defenses based on certain cost justifications and/or changing conditions, see 15 U.S.C. § 13(a), Maxon has not asserted either of them.
. It is entirely possible that Maxon's assertion that the "two purchaser requirement” (or the so-called "contemporaneous” sales requirement) was not satisfied is an assault on the latter portion of the second element, or possibly the second element in its entirety. Likewise, this argument may go to the fourth element, by disputing that the price discrimination had a prohibited effect on competition. Or it may be an attempt to undermine both. Although it is possible to envision a situation where the direction of the defendant’s thrust will make a difference in the analysis, under the facts of this case it is a distinction without a difference.
. In Chroma Lighting, the defendant argued that the plaintiff could not have been in competition with either of its alleged competitors because it purchased its product from the defendant only after he had a customer’s order in hand. Ill F.3d 653 (9th Cir.1997). According to the defendant’s theory, if the plaintiff purchased a product from the defendant after he had already “sold” that product to a customer, then the plaintiff could not be in competition for the resale of that particular product. Id. Defendant also argued that if the plaintiff did not have a customer bid, then he would have no reason to purchase a product, and there could be no “contemporaneous” sale. Id. The court found the defendant’s theory "unconvincing.” Id. Whether or not the plaintiff actually purchased his inventory before or after he made customer sales does not change the fact that he competed for each sale on the basis of the price he expected to get from the defendant. This evidence was sufficient to satisfy the Robinson-Patman Act’s requirement that discriminatory sales be “substantially contemporaneous. "I'd.
.
Innomed Labs, LLC v. Alza Corp.,
. Maxon does argue that IBS was not in competition at the time of what it characterizes as the "actual purchase” of its products by IBS, because the competition ended when the contract was awarded to the lowest bidder. However, as explained below, it is precisely because the relevant period of competition is prior to the award of the bid that the quote given by Maxon at that time carries the discriminatory price effect.
.Moreover, even if this court had found that there was a contemporaneous requirement and applied it against IBS, other courts have held that "an established customer who is currently purchasing one type of goods at a higher price and is denied the right to buy a lower-priced good of ‘like grade and quality’ which is being sold to a competitor can sue under the Act.”
See, e.g., Fusco v. Xerox Corp.,
. The court reasoned that:
"[o]nce it was awarded the bid, which was a prerequisite to becoming a purchaser ... [the plaintiffs] 1970 contract was assured to it to the exclusion of all other suppliers regardless of any discrepancy in prices paid on underlying subcontracts. In the same fashion, the [tertiaiy-line customer] pledged itself unconditionally under the 1971 contract to purchase the specified quantity of finished plugs exclusively from [the competitor]. The very nature of these mutually exclusive commitments in the respective contracts meant that [the plaintiff and the competitor] could not have been 'in competition' with respect to their separate purchases from [the defendant] pursuant to the government contracts. Therefore, while the price discrepancy between the two actual purchases (as distinguished from the bids related to the 1971 contract) could have affected [the plaintiff’s] profits under the addition to its 1970 contract, this discrimi *886 nation in no way diminished [his] competitive ability in that ... market.” Id. at 1066-67.
.
See M.C. Manufacturing,
. Both Maxon and IBS have failed to raise an important legal issue which has not been addressed by this Circuit; namely, in secondary-line cases, whether after
Brooke Group Ltd. v. Brown & Williamson Tobacco Corp.,
. The Table (which appears to be from January 1996) list the following price differentials: "End Products” are offered to the OEM at (.80), and to the Resaler at (.90) — a difference of 14%; "Parts and Subassemblies” are offered to the OEM at (.85), and to the Resaler at (.93) — a difference of 9.4%; "Regulators, Pipe Trains” are offered to the OEM at (.90), and to the Resaler at (.95) — a difference of 5.5%; "SOV-STO End Products” are offered to the OEM at (.66) and to the Wholesaler at (.73) — a difference of 10.6%; "SOV-STO Parts % Subs, Modular End Products” are offered to the OEM at (.80) and to the Wholesaler at (.90) — a difference of 14%; "Modular Parts and Subassemblies” are offered to the OEM at (.90), with no listed price for Wholesaler.
. Moreover, even if this court had determined that deposition, standing alone, was insufficient to create a genuine issue of material fact as to the duration of the alleged discrimination, when combined with the differing prices in the Table, Flora’s deposition creates a genuine issue of material fact con *889 cerning the duration of the alleged price discrimination. Therefore, even under this view, summary judgment would not be appropriate.
. The
Morton Salt
inference, as applied in
Allied II,
does not require the plaintiff to prove that price discrimination was the sole or "but for” cause of his injury. It is enough that the challenged price discrimination is a material cause of that injury.
. See also, Flora Deposition, at 202 ("They ¡TMI, a competitor,] might have built 150 [gas trains], but to my salesmen’s recollection we lost a hundred of them over the last 10 years at least because ... TMI is an air house manufacturer. Air house manufacturers have higher volumes, bigger valves, and so [for] all the bigger valves we have to use Maxon and so we’re always at a disadvantage with that.”).
. In
Allied I,
the defendant manufacturer signed a contract with a certain one of the plaintiff’s competitors which allowed that competitor to purchase the product at issue for 10 percent below warehouse distribution prices.
. At the very least, these pieces of evidence, viewed in the light most favorable to the non-moving party, create a genuine issue of material fact that precludes the granting of summary judgment.
.See D.E. Rogers Assocs., Inc. v. Gardner-Denver Co.,
. While IBS does assert that Maxon is the exclusive provider of certain models of valves and burners, this does not necessarily amount to a claim that Maxon has monopolistic power within the relevant market. Moreover, IBS has failed to come forward with sufficient evidence to support such a claim, even if it were to be implied from the facts presented.
. Applying this exception to the facts of its case, the court found that "the individual payments to [the defendant] were only a manifestation of the previous agreement. The individual payments therefore do not constitute a 'new and independent act,’ as required to restart the statute of limitations.” Id.
. The Court in Zenith observed, however, that when a continuous antitrust violation is alleged, a cause of action accrues each time a plaintiff is injured by an act of the defendants: In the context of a continuing conspiracy to violate the antitrust laws ... each time a plaintiff is injured by an act of the defendants a cause of action accrues to him to recover the damages caused by that act and ... as to those damages, the statute of limitations runs from the commission of the act.
